2022
DOI: 10.22541/au.164167102.22702519/v1
|View full text |Cite
Preprint
|
Sign up to set email alerts
|

Identification of novel miRNA targets in CHO cell lines and characterization of their impact on protein N-glycosylation

Abstract: CHO cell lines are a workhorse for the production of pharmaceutical proteins, but show some limitations in the variability and stability of N-glycosylation profiles. One promising approach to addressing this at the required systems-level is miRNA, which can regulate a large number of genes and have predictable targets. Herein, we first identified de novo 656 potential miRNAs in the CHO genome based on a combination of literature, database searching, and miRNA sequencing. We further sequenced mRNA from the same… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
2
1

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(1 citation statement)
references
References 42 publications
0
1
0
Order By: Relevance
“…Therefore, the use of miRNAs as engineering tools can be challenging, but offers the opportunity to control entire cellular pathways without any energy‐consuming translational burden [ 15 ]. Therefore, miRNA‐associated engineering approaches were established as efficient tools in CHO cell line engineering for the improvement of productivity, fine‐tuning of product quality, the enhancement of cell growth and survival, and the modulation of metabolic pathways [ 3 , 6 , 8 , 16 , 17 , 18 , 19 , 20 , 21 , 22 , 23 , 24 , 25 , 26 , 27 , 28 , 29 , 30 ]. However, quality‐relevant characteristics of therapeutic proteins like antibody fucosylation have so far been engineered using standard techniques like knock‐out of genes [ 5 , 31 , 32 , 33 , 34 ], siRNA mediated transient gene knock‐down [ 27 , 35 , 36 ] or miRNA‐mediated transient gene knock‐down [ 37 ] only.…”
Section: Introductionmentioning
confidence: 99%
“…Therefore, the use of miRNAs as engineering tools can be challenging, but offers the opportunity to control entire cellular pathways without any energy‐consuming translational burden [ 15 ]. Therefore, miRNA‐associated engineering approaches were established as efficient tools in CHO cell line engineering for the improvement of productivity, fine‐tuning of product quality, the enhancement of cell growth and survival, and the modulation of metabolic pathways [ 3 , 6 , 8 , 16 , 17 , 18 , 19 , 20 , 21 , 22 , 23 , 24 , 25 , 26 , 27 , 28 , 29 , 30 ]. However, quality‐relevant characteristics of therapeutic proteins like antibody fucosylation have so far been engineered using standard techniques like knock‐out of genes [ 5 , 31 , 32 , 33 , 34 ], siRNA mediated transient gene knock‐down [ 27 , 35 , 36 ] or miRNA‐mediated transient gene knock‐down [ 37 ] only.…”
Section: Introductionmentioning
confidence: 99%